1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF286B CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA ATP6V0E1 CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA ANAPC13 CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA ANO8 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA TMSB15B CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA ZCCHC11 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA TP53 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA MATR3 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA RP5-1028K7.3 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA NINL CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV